ANDI CENTRE OF EXCELLENCE IN MEDICINAL CHEMISTRY
IThemba Pharmaceuticals (iThemba)
IThemba Pharmaceuticals (iThemba) is South Africa’s only medicinal chemistry-based drug discovery company dedicated to the discovery and development of new treatments for infectious diseases, with a particular focus on tuberculosis (TB). It was established by a group of international academics who shared their concerns about the lack of capacity in Africa to address endemic diseases and the absence of career opportunities for young medicinal chemists graduating from the regions tertiary institutions. The Technology Innovation Agency is the major shareholder.